PMID- 15832422 OWN - NLM STAT- MEDLINE DCOM- 20050609 LR - 20190430 IS - 1007-9327 (Print) IS - 2219-2840 (Electronic) IS - 1007-9327 (Linking) VI - 11 IP - 16 DP - 2005 Apr 28 TI - Expression of cellular FLICE-inhibitory protein and its association with p53 mutation in colon cancer. PG - 2482-5 AB - AIM: To investigate the expression of cellular FLICE (Fas associated death domain-like IL-1beta-converting enzyme)-inhibitory protein (c-FLIP) and its association with p53 mutation in colon cancer. METHODS: Immunohistochemical staining of c-FLIP and mutant p53 by using specific antibodies was performed by the standard streptavidin-peroxidase technique for 45 colon cancer tissue samples with matched normal tissues. Semi-quantitative reverse transcriptional (RT)-PCR was used to measure c-FLIP mRNA levels. t-test statistical method was used in data analyses. RESULTS: c-FLIP mRNA was expressed in all colon cancer tissues and its level (0.63+/-0.12) was significantly higher than that in normal tissues (0.38+/-0.10, P<0.01). Immuno-histochemically, c-FLIP protein was also expressed in all colon cancers (45/45) and 71.1% (32/45) showed an intense immunostaining, in contrast, 93.3% (42/45) of normal colonic mucosa showed positive staining and none of them immunostained intensely. The quantity of c-FLIP protein was significantly higher in cancer tissues than in normal mucosa (7.04+/-1.20 vs 5.21+/-0.86, P<0.01). Positive staining of mutant p53 protein was found in 60% (27/45) colon cancers. c-FLIP mRNA level was decreased in p53 positive group compared with p53 negative cancer tissues (0.59+/-0.13 vs 0.69+/-0.14, P<0.01), but c-FLIP protein had a significantly higher level in p53 positive cancer tissues than in negative ones (7.57+/-1.30 vs 6.25+/-1.27, P<0.01). CONCLUSION: c-FLIP is specially overexpressed in colon cancers and it might contribute to carcinogenesis of normal colonic mucosa. p53 may exert transcriptional upregulation effects on c-FLIP gene and more potent effects on promoting the degradation of c-FLIP protein. FAU - Zhou, Xiao-Dong AU - Zhou XD AD - Department of Gastroenterology, Renmin Hospital of Wuhan University, Jiefang road 238, Wuhan 430060, Hubei Province, China. zhouxd7612@hotmail.com FAU - Yu, Jie-Ping AU - Yu JP FAU - Chen, Hong-Xia AU - Chen HX FAU - Yu, Hong-Gang AU - Yu HG FAU - Luo, He-Sheng AU - Luo HS LA - eng PT - Journal Article PL - United States TA - World J Gastroenterol JT - World journal of gastroenterology JID - 100883448 RN - 0 (CASP8 and FADD-Like Apoptosis Regulating Protein) RN - 0 (CFLAR protein, human) RN - 0 (Intracellular Signaling Peptides and Proteins) RN - 0 (RNA, Messenger) RN - 0 (Tumor Suppressor Protein p53) SB - IM MH - Adult MH - Aged MH - Aged, 80 and over MH - CASP8 and FADD-Like Apoptosis Regulating Protein MH - Colonic Neoplasms/*genetics/metabolism/*physiopathology MH - Female MH - Gene Expression Regulation, Neoplastic MH - Humans MH - Immunohistochemistry MH - Intracellular Signaling Peptides and Proteins/*genetics/metabolism MH - Male MH - Middle Aged MH - Mutation MH - RNA, Messenger/analysis MH - Tumor Suppressor Protein p53/*genetics/metabolism PMC - PMC4305639 EDAT- 2005/04/16 09:00 MHDA- 2005/06/10 09:00 PMCR- 2005/04/28 CRDT- 2005/04/16 09:00 PHST- 2005/04/16 09:00 [pubmed] PHST- 2005/06/10 09:00 [medline] PHST- 2005/04/16 09:00 [entrez] PHST- 2005/04/28 00:00 [pmc-release] AID - 10.3748/wjg.v11.i16.2482 [doi] PST - ppublish SO - World J Gastroenterol. 2005 Apr 28;11(16):2482-5. doi: 10.3748/wjg.v11.i16.2482.